network member

University of Alabama at Birmingham Comprehensive Cancer Center

1824 Sixth Avenue, Wallace Tumor Institute, South Birmingham, AL 35294 - USA
University of Alabama at Birmingham Comprehensive Cancer Center

About Network Member

The University of Alabama at Birmingham Comprehensive Cancer Center is the only National Cancer Institute-designated comprehensive cancer center located in a six-state area that includes Alabama, Arkansas, Georgia, Louisiana, Mississippi, and South Carolina. From bench to bedside, the UAB Comprehensive Cancer Center is at the forefront of improving cancer prevention, diagnosis, and treatment. Researchers have pioneered advances in chemotherapy, surgery, radiotherapy, immunotherapy, and nutrition. The UAB Comprehensive Cancer Center offers a full array of treatment options from multidisciplinary clinics filled with experts from across cancer fields to the latest technology. The center is home to more than 350 physicians and researchers, many of whom are internationally and nationally recognized for their expertise in oncology. The Cancer Center treats an estimated 5,000 new patients each year. Website: The University of Alabama at Birmingham Comprehensive Cancer Center
Currently Enrolling

HCRN-BRE20-468

A Phase II Study of Ribociclib And Endocrine Treatment of Physician’s Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR Study)
Cancer areas:Breast
Fred & Pamela Buffett Cancer Center
New York University Cancer Institute
Orlando Health Cancer Institute
Parkview Research Center
Penn State Cancer Institute
Providence Cancer Institute
Rutgers Cancer Institute of New Jersey
The Ohio State University
Tufts Medical Center
University of Alabama at Birmingham Comprehensive Cancer Center
University of Arizona Cancer Center
University of Illinois Cancer Center
University of Iowa Holden Comprehensive Cancer Center
University of Michigan Health-West
University of Michigan Rogel Cancer Center
University of Virginia Cancer Center
University of Wisconsin Carbone Cancer Center
Currently Enrolling

TBCRC047

Innovative Combination Immunotherapy for Metastatic Triple Negative Breast Cancer (TNBC): A Multicenter, Multi-Arm Translational Breast Cancer Research Consortium Study
Cancer areas:Breast
Dana-Farber Cancer Institute
Duke Cancer Institute
Georgetown Lombardi Comprehensive Cancer Center
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The University of Chicago Medicine Comprehensive Cancer Center
UC San Francisco
University of Alabama at Birmingham Comprehensive Cancer Center
University of North Carolina Lineberger Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Enrollment Closed

HCRN-BRE18-334

A Phase II circulating tumor DNA enriched, genomically directed post-neoadjuvant trial for patients with residual triple negative breast cancer (PERSEVERE)
Cancer areas:Breast
Advocate Aurora Research Institute (Illinois)
Aurora Health Care
Froedtert & the Medical College of Wisconsin
Georgetown Lombardi Comprehensive Cancer Center
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Miami Cancer Institute at Baptist Health, Inc.
Novant Health Oncology Specialists
The University of Chicago Medicine Comprehensive Cancer Center
University of Alabama at Birmingham Comprehensive Cancer Center
University of Wisconsin Carbone Cancer Center
UT Health San Antonio MD Anderson Cancer Center